Billiontoone (NASDAQ:BLLN) Shares Gap Down – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $105.94, but opened at $98.26. Billiontoone shares last traded at $100.7940, with a volume of 180,266 shares trading hands.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. BTIG Research cut their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. JPMorgan Chase & Co. upped their price objective on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Billiontoone in a research report on Friday, May 1st. Finally, Wells Fargo & Company cut their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 5th. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Billiontoone presently has a consensus rating of “Moderate Buy” and a consensus price target of $122.43.

Billiontoone Stock Down 7.4%

The company has a fifty day moving average price of $79.11. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The stock has a market capitalization of $4.51 billion and a P/E ratio of 471.69.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.33. The business had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The company’s revenue for the quarter was up 83.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.39) earnings per share. Equities research analysts forecast that Billiontoone, Inc. will post 0.63 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Billiontoone

Several large investors have recently modified their holdings of BLLN. Green Alpha Advisors LLC acquired a new position in Billiontoone in the 4th quarter valued at $436,000. FNY Investment Advisers LLC purchased a new position in Billiontoone during the fourth quarter worth about $497,000. Massachusetts Financial Services Co. MA acquired a new stake in Billiontoone in the fourth quarter valued at about $13,373,000. Baillie Gifford & Co. purchased a new stake in Billiontoone in the 4th quarter valued at approximately $103,786,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Billiontoone during the 4th quarter worth approximately $1,348,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.